Your session is about to expire
← Back to Search
Ketone Ester for Heart Failure
Study Summary
This trial will test whether a ketone ester drink can help people with heart failure exercise more by improving heart function or muscles. The drink is "generally regarded as safe" by the FDA.
- Diastolic Heart Failure
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have been following a specific high-fat, low-carb diet or taking certain medications in the past week.You have a serious lung disease that needs oxygen or recent treatment with steroids or antibiotics for a lung flare-up.You have severe liver disease or drink a lot of alcohol.You have conditions that make it hard for you to do exercise or stress testing, such as certain heart conditions, very high blood pressure, or kidney problems.You have a heart valve condition that is moderate or severe based on a screening heart ultrasound.You have type 1 diabetes.Your heart's pumping ability is not strong enough, with a previous measurement of less than 45%.You have evidence of high pressure in the heart, such as specific measurements during a medical test or a history of acute heart failure with symptoms of fluid overload.You have chest pain caused by blocked arteries in your heart or you have significant blockages in your heart arteries that have not been treated with surgery or other procedures, according to the doctor.Your heart pumps blood out effectively.
- Group 1: Ketone ester
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the eligibility requirements for participating in this research study?
"Patients aged between 18 and 85, who have been diagnosed with heart failure with preserved ejection fraction (hfpef) are invited to take part in this medical trial. To be eligible they must also possess an enlarged left atrium, display New york Heart Association class II or III symptoms, and present a Mitral E/e' ratio exceeding 14."
Has the FDA granted approval for Ketone ester?
"Ketone ester has undergone some safety testing, which justifies its score of 2 on the 1-3 scale. However, there is yet to be any efficacy data generated for this medication."
Is this experiment open to participants above the age of twenty-five?
"The enrollment criteria for this clinical trial necessitates that participants are aged between 18 and 85."
What is the cap for enrollment in this medical research study?
"Affirmative. The clinicaltrial.gov portal attests that this medical trial is currently enrolling participants, with the first posting on October 6th 2020 and a recent update on November 11th 2022. Specifically, 20 people are sought for research at 1 center of study."
Is the recruitment process for this research endeavor still open?
"Affirmative. Clinicaltrials.gov confirms that this medical experiment, which was first unveiled on October 6th 2020, is currently recruiting participants. As many as 20 individuals need to be signed up from a single location."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger